SHARE

Aviva’s health business in-force premiums rise 14% as operating profit target approached

The insurer’s health division reported 14% growth in in-force premiums and remains on track to reach its £100m 2026 profit goal. Protection and health sales slipped 5% to £384m, reflecting market-wide moderation in new policy demand.

Certification Note

Certified B Corporation” is a trademark licensed by B Lab, a private non-profit organization, to companies like ours that have successfully completed the B Impact Assessment (“BIA”) and therefore meet the requirements set by B Lab for social and environmental performance, accountability, and transparency. It is specified that B Lab is not a conformity assessment body as defined by Regulation (EU) No 765/2008, nor is it a national, European, or international standardization body as per Regulation (EU) No 1025/2012. The criteria of the BIA are distinct and independent from the harmonized standards resulting from ISO norms or other standardization bodies, and they are not ratified by national or European public institutions.